Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs SoFi Technologies Inc (SOFI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs SoFi Technologies Inc — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.5 (market cap $5.08B), while SoFi Technologies Inc trades at $14.42 (market cap $18.37B). The key difference: SoFi Technologies Inc is far larger — about 3.6× Oruka Therapeutics Inc. Common Stock's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, SoFi Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and SoFi Technologies Inc for 60 Days on average.
| ORKA | SOFI | |
|---|---|---|
Market Cap | $5.08B | $18.37B |
Volume | 685,276 | 91,795,295 |
Sector | Health | Financials |
52-Week High | $113.08 | $32.21 |
52-Week Low | $26.19 | $14.22 |
Typical Hold Time | 0 Days | 60 Days |
Enterprise Value | $4.21B | $18.65B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SoFi Technologies (SOFI) trades at $15.24, up slightly by 0.07% on the day, but remains under pressure with a bearish technical signal. The stock has beaten earnings expectations for three consecutive quarters, with Q3 2026 results pending. Revenue growth is robust, climbing from $1.6B in 2022 to $3.6B in 2025, though net income margins have fluctuated. Analyst consensus is a 'Buy' with a $21.08 price target, but technical indicators and recent news highlight volatility in the fintech sector.
The outlook for SOFI hinges on sustained loan originations and stablecoin initiatives driving future revenue, but risks include interest rate sensitivity and competitive pressures. With the stock near its 52-week low of $15.00, upside exists if earnings continue to exceed forecasts, yet investor caution prevails amid macroeconomic headwinds and mixed analyst sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About SoFi Technologies Inc
SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →
